The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

Recruiting

Phase N/A Results N/A

Trial Description

The study will focus on the impact of communal singing on patients with stroke and their personal caregivers. Forty post-stroke patients will be randomly assigned to two groups: the first group of 20 stroke survivors and their caregivers (up to 40 total participants) will receive 6 months (approximately 24 sessions) of music therapy. The second control groups of 20 stroke survivors and their caregivers will receive standard post-stroke care

Detailed Description

The study will focus on the impact of communal singing on patients with stroke and their personal caregivers. Forty post-stroke patients will be randomly assigned to two groups: the first group of 20 stroke survivors and their caregivers (up to 40 total participants) will receive 6 months (approximately 24 sessions) of music therapy. The second control groups of 20 stroke survivors and their caregivers will receive standard post-stroke care.
All enrolled participants will be assessed on their mood, past music experience and music genre preference (music therapy assessment). They will complete the abridged Beck (BDI-2-fastscreen) questionnaire, the stoke and aphasia quality of life scale; a Likert which measures distress; the Western Aphasia Battery (WAB); the NIH Stroke Scale (SS); the Figely compassion scale; and the driving scene test (Stern and White); and the Rankin. In additional we will take saliva samples from all participants to measure hormone levels.

Conditions

Interventions

  • Communal singing Behavioral
    ARM 1: Kind: Experimental
    Label: Communal singing
    Description: Stroke survivors and caregivers will participate in a weekly singing group and be assessed for aphasia, mood, quality of life outcomes.

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Parallel Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary Change in mood and quality of life as indicated through saliva (cortisol and melatonin sampling) 6 months No
Secondary Change in language aphasia outcome improvement 6 months No
Primary Change in mood and quality of life as indicated through saliva (cortisol and melatonin sampling) 6 months No
Secondary Change in language aphasia outcome improvement 6 months No

Sponsors